Both in Pharmaceuticals
Jazz Pharmaceuticals vs Summit Therapeutics
Over the past year JAZZ returned +80.1% and SMMT returned −22.5%; their daily moves had a correlation of 0.11.
JAZZ +80.1% SMMT −22.5%Growth of $1, one year, split-adjusted
| Metric | JAZZ | SMMT |
|---|---|---|
| Price | $232.35 | $16.39 |
| Market cap | $15.08B | $13.08B |
| Today | −2.49% | +5.88% |
| 1 month | −5.0% | +19.4% |
| 6 months | +26.9% | −3.5% |
| Year to date | +36.7% | −6.3% |
| 1 year | +83.0% | −21.8% |
| Revenue growth (YoY) | +15.5% | — |
| Gross margin | 90.4% | — |
| Net margin | 16.0% | — |
| P/E (TTM) | 16.0× | — |
| Price / sales | 3.3× | — |
| Net cash | -$2.15B | $690.7M |
| Dividend yield | — | — |
| Volatility (60d) | 27.2% | 69.5% |
| Short % of float | 7.5% | 29.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).